1. Introduction
===============

DF is an arboviral disease caused by dengue virus (DENV). DENV belongs to the family Flaviviridae, genus *Flavivirus*. It is a mosquito-borne pathogen that is traditionally transmitted by *Aedes aegypti* mosquito and to a lesser extent, *Aedes albopictus* ([@veaa026-B59]). In terms of disease burden and risk potential, DENV is one of the most important arboviral pathogens. One-third of the world's population (∼2.5 billion people) is at risk of infection with DENV and it is estimated that approximately 390 million infections occur yearly in the tropical and subtropical regions ([@veaa026-B4]; [@veaa026-B6]). DENV comprises four antigenically distinct serotypes, DENV 1-4. Infection with either of the DENV serotypes generally causes dengue fever (DF), a self-limiting febrile illness that often lasts between 2 and 10 days ([@veaa026-B53]). Some patients with DF can progress to develop one of two life-threatening conditions, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). DHF is characterized by hemorrhage and thrombocytopenia while DSS occurs due to excessive plasma leakage ([@veaa026-B16]). Case fatality ratios due to DENV infections vary across populations, with an average of 5 percent being reported in some studies ([@veaa026-B29]). Some of the factors contributing to these variations and the risk of development of life-threatening conditions include the genetic constitution of the virus, the genetic make-up of the individual as well as previous infection with a different serotype ([@veaa026-B18]; [@veaa026-B57]). The spread and co-circulation of the serotypes have caused epidemics with increasing frequency and magnitude. Efforts to control the virus still depend on vector control strategies, given that the recent attempts to introduce a dengue vaccine have faced numerous challenges and have resulted in little success ([@veaa026-B54]; [@veaa026-B32]; [@veaa026-B48]).

DENV has a single-stranded, positive sense nonsegmented RNA genome. Like many other RNA viruses, DENV is fast evolving due to the error-prone RNA-dependent RNA polymerase, leading to the formation of several genotypes within each DENV serotype over the years ([@veaa026-B53]; [@veaa026-B51]). This evolution of the virus has been correlated with epidemic activity, and occasionally severity of the disease caused by the virus ([@veaa026-B17]; [@veaa026-B4]; [@veaa026-B5]). DENV-2 has been divided into six different genotypes that include Asian I (AI), Asian II (AII), Cosmopolitan (C), American (AM), Asian/American (AA), and sylvatic (S) genotypes. These genotypes were suggested based on phylogeny of DENV-2 using envelope gene sequences ([@veaa026-B49]). Recent advances in full-genome sequencing, however, have led to generation of complete DENV-2 genomes which has revealed further diversity within DENV-2 genotypes and thus suggestions for further groupings ([@veaa026-B1]; [@veaa026-B51]). To ensure consistency throughout this study, the Cosmopolitan genotype has been divided into three lineages; Cosmopolitan-I (C-I), Cosmopolitan-II (C-II), and Cosmopolitan-III (C-III) ([@veaa026-B1]).

In Kenya, DF has been reported since World War II ([@veaa026-B30]), with serological evidence recorded between 1966 and 1968 ([@veaa026-B15]) suggesting that the virus had been circulating in coastal Kenya during that time. However, it was not until 1982 that the first dengue outbreak was documented in the Coastal towns of Malindi and Kilifi, which was subsequently determined to have been driven by DENV-2 ([@veaa026-B19]). After this initial outbreak, no case of dengue disease was documented in this region for a period of almost two decades. In 1997, DENV-2 was isolated from a child with febrile illness in Kilifi, Kenya ([@veaa026-B43]), suggesting possible continued active transmission of DENV in the region. This was further reinforced by the detection in 2004 of DENV IgG antibodies from human serum in Malindi ([@veaa026-B31]). Between 2011 and 2014, an outbreak involving DENV-1, 2, and 3 was reported in Mandera, northeastern Kenya, and Mombasa, coastal Kenya ([@veaa026-B24]; [@veaa026-B36]). In 2017, another outbreak involving DENV-2 was reported in Wajir and Mandera in North Eastern Kenya as well as Malindi, Kilifi, and Mombasa, on the Kenyan Coast ([@veaa026-B61]).

Considering the role of DENV-2 in the epidemiology of dengue disease in Kenya, we investigated the spatial origin and evolutionary inferences of the Kenyan DENV-2 lineages collected during the 2013--4 and 2017 outbreaks. The findings from this study extend our understanding of the origin of the two circulating lineages of DENV-2, C-I and C-II, in Kenya. Furthermore, the newly generated sequences add to the number of DENV-2 genomes currently available from Africa, where the number of genomes remains limited despite the numerous reported outbreaks.

2. Methods
==========

2.1 Ethical consideration
-------------------------

The study was carried out on a protocol approved by the Walter Reed Army Institute of Research (\#2189) and the Kenya Medical Research Institute's Institutional Review Boards (\#3035), as an overarching protocol guiding investigation and reporting of arbovirus/hemorrhagic fever outbreaks in Kenya. Because blood samples were collected from an outbreak and no human data were collected, this was deemed a nonhuman research study and no consent was required. The protocol was approved for additional analysis of outbreak samples and for publication of results.

2.2 Samples
-----------

Samples sequenced in this study were collected during dengue outbreaks between 2013 and 2017. Serum samples were received at the Arbovirus and Viral Hemorrhagic Fever (VHF) laboratory, Kenya Medical Research Institute (KEMRI), and stored at −80°C.

2.3 RNA extraction and sequencing
---------------------------------

Original specimen material stored at −80°C was aliquoted and used for viral RNA extraction. Viral RNA was extracted using QiaAmp Viral RNA Minikit (Qiagen, MD, USA), according to the manufacturer's instructions. Following extraction, Superscript III cDNA Synthesis Kit (Invitrogen, Carlsbad, CA, USA) was used for first-strand cDNA synthesis. Twelve primer pairs ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were used to amplify 12 overlapping targets covering the entire genome of DENV-2. The amplicons were used to prepare libraries for next generation sequencing (NGS). In brief, the amplicons from each sample were pooled in equal volumes and cleaned using Agencourt Ampure XP beads (Beckman Coulter, Beverly, MA, USA) then quantified using Qubit 3.0 dsDNA HS Assay Kit (Thermo Fisher Scientific Inc., Wilmington, DE, USA). Libraries were then prepared using the Nextera XT DNA Sample Prep Kit (Illumina, San Diego, CA, USA), using 1 ng of DNA from the cleaned amplicons. The samples were uniquely barcoded using Nextera XT Index Kit (Illumina, San Diego, CA, USA). Library normalization was done using the standard library normalization process according to the manufacturer's instructions. The normalized libraries were pooled in equal volumes and sequenced on an Illumina Miseq platform, using a 2 × 300 base paired-end reads. Raw sequence reads were inspected for quality using FASTQC ([@veaa026-B2]). Prinseq-lite-0.20.4 ([@veaa026-B44]) was used to filter the low-quality reads and *de novo* sequence assembly was performed with SPAdes v3.10 ([@veaa026-B35]). Reference-guided assembly was performed with Ngs_mapper pipeline ([@veaa026-B33]). The assembly followed default criteria set by the pipeline whereby the minimum base-calling quality of 25 and minimum mapping quality of 25 as well as a depth of coverage of 10 was used. Furthermore, every unambiguous nucleotide that was called had to have occurred in at least 80% of the assembled reads in the assembly. The sequences generated in this study were submitted to GenBank under accession numbers \[MN577551--MN577564\].

2.4 Sequence collation and screening of recombinants
----------------------------------------------------

Genomes from this study were combined with previously sequenced genomes from the Kenyan coast covering the period 2013--7 ([@veaa026-B24]; [@veaa026-B14]; [@veaa026-B21]). In addition, DENV-2 sequences were downloaded from Virus Pathogen Resource (ViPR) and used for the initial phylogenetic analysis. These sequences belong to the different genotypes of DENV-2, excluding the sylvatic strains. For a more in-depth evolutionary analysis, we downloaded all the cosmopolitan genotype sequences from ViPR, containing the date of isolation and country of origin. Sequences that did not have this information were manually assigned through literature search and those that could not be assigned were excluded. To normalize the number of sequences from the individual countries, we used CD-HIT ([@veaa026-B13]) to cluster the sequences from Countries that had a disproportionately high number of sequences, using a similarity threshold of 0.98--0.99 depending on the number of clusters from each country. We randomly picked one sequence from each cluster and used them for subsequent analyses.

Alignments were obtained using MAFFT v7.428 ([@veaa026-B23]), Jalview v2 ([@veaa026-B52]) was used to manually edit the alignments. The sequences were then trimmed to only remain with the open reading frames of DENV-2, with further trimming being performed to remove sites that had long stretches of missing bases, leading to a final alignment of 7,040 nt. Recombination detection was performed on each of these alignments in the RDP4 software suite ([@veaa026-B28]) using RDP, GENECOV, and MAXCHI methods. RECSCAN and SISCAN methods were used for confirmatory recombination scans. Significant recombination was considered when it was detected by all the three methods and at least one confirmatory method. We removed the sequences that were detected to be recombinants based on these criteria. Each of the alignments was further confirmed by using the Genetic Algorithm for Recombination Detection (GARD) ([@veaa026-B25]) in datamonkey webserver. No evidence of recombination was found in the final alignments.

2.5 Phylogenetic analysis
-------------------------

Maximum Likelihood (ML) and Bayesian phylogenies were inferred using RAxML ([@veaa026-B45]) and MrBayes V3.2.6 ([@veaa026-B42]), respectively. The best-fit substitution model for our datasets was determined by both the AIC and BIC tests in jModelTest2 ([@veaa026-B10]) as the general-time reversible model with gamma distribution (GTR+ G). This model was applied in both analyses. RAxML was performed for 2000 bootstrap replications and MrBayes implemented the Metropolis-coupled Markov Chain Monte Carlo (MCMCMC) method, with three hot chains and one cold chain, and the analysis was run for 5 million generations with 25% burn-in. The analysis was performed in duplicate and the convergence of runs was determined by the average standard deviation in split frequencies of less than 0.01. Because majority of the additional DENV-2 genomes from the 2013 to 2014 outbreak period were only sequenced on their capsid/premembrane (C/PrM) gene region, we also inferred the phylogenetic tree for the partial C/PrM region. All the additional C/PrM sequences from Kenya as well as other closely related C-I and C-II sequences were downloaded and combined with the BEAST dataset (C/PrM region only). ML trees were then inferred, using the GTR+G, as determined by jModelTest2.

2.6 Molecular clock analysis and phylogeography
-----------------------------------------------

Time-calibrated phylogeny and phylogeography analyses were performed using the Cosmopolitan genotype sequence dataset only. Prior to performing this analysis, TempEst v1.5.3 ([@veaa026-B39]) was used to assess the clock-likeness of our data by estimating the root-to-tip regression. We found a strong signal (correlation coefficient = 0.7923), suggesting the dataset was appropriate for the estimation of temporal parameters. The analysis was then carried out using the Bayesian Markov Chain Monte Carlo (MCMC) method, implemented in BEAST V1.10.4 ([@veaa026-B46]). For a more tractable postanalysis interpretation and reduced computational complexity, we collapsed the country of origin of the sequences to five distinct regions as their trait location; Africa, SE Asia, South Asia, East Asia, and Oceania. The Kenyan Sequences were assigned 'Kenya' as their trait location. We applied a relaxed molecular clock (uncorrelated lognormal) and a nonparametric Bayesian Skyline model, with ten groups, to estimate past population dynamics. The best-fit substitution model of GTR+G, as suggested by jModelTest2 ([@veaa026-B10]), was applied in this analysis. An asymmetric trait substitution model was used and reconstruction of ancestral states at all nodes was activated. Two independent runs of 250 million each, sampling after every 25,000 steps, were performed and the runs were combined after removal of 10 percent of the trees as burn-in. The convergence of runs was checked with Tracer v1.7.1 ([@veaa026-B40]) to ensure that adequate mixing was achieved and that all parameters had reached an adequate effective sample size (ESS \> 200). The maximum-clade credibility tree was summarized with TreeAnnotator and visualized in FigTree v1.4.4.

3. Results
==========

Overlapping PCR amplicon targets for fourteen DENV-2 isolates were obtained and subjected to NGS. We generated consensus sequences for all fourteen isolates which had varying lengths of between 8,424 and 10,292 nt, with an average length of 9,562 nt. Thirteen of the isolates sequenced in this study originated from Mombasa and one originated from Wajir, northeastern Kenya. The Wajir isolate was collected in June of 2014, during the northeastern Kenya dengue outbreak ([@veaa026-B24]; [@veaa026-B36]). We downloaded a further fourteen full-genome sequences from the Kenyan coast, which were then combined with the sequences generated in this study for subsequent analysis.

3.1 C-I and C-II lineages of the cosmopolitan genotype were circulating in Kenya
--------------------------------------------------------------------------------

Both ML and Bayesian phylogenies were concordant. They showed that 93% (26 of the 28) of the isolates from Kenya fell within a single and well-supported monophyletic clade (Bootstrap, BS = 100; Posterior probability, PP = 1) ([Fig. 1A](#veaa026-F1){ref-type="fig"} and [Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). This clade clustered under the C-I lineage of the Cosmopolitan genotype and was closely related to isolates from South Asia; more specifically India, Pakistan, and Sri Lanka. Our phylogenetic analysis also revealed the circulation of a comparatively divergent strain of DENV-2. This strain was represented by one isolate from Mombasa and one isolate from Wajir, which was isolated during the 2013--4 dengue outbreak in the northeastern part of Kenya (BS = 100, PP = 1) ([Fig. 1A](#veaa026-F1){ref-type="fig"} and [Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). The Mombasa/Wajir genomes clustered under the C-II lineage of the Cosmopolitan genotype. They were closely related to genomes sampled in Burkina Faso from 1983 to 2016 and those from Indonesia sampled in 1975--6 as well as a genome from one case originating from Niger ([Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). The long branch leading to this Kenyan strain suggests a lack of data that would provide a clearer picture of the geographic distribution of this particular strain.

![(A) Mid-point rooted ML phylogenetic Tree of 154 genome sequences isolated globally. Sequences from Kenya are highlighted with red tips representing sequences from 2017 outbreak and blue tips representing the 2013/4 outbreak sequences. The annotations shown are represented by; C, Cosmopolitan genotype; C-I, Cosmopolitan-I lineage; C-II, Cosmopolitan-II lineage; C-III, Cosmopolitan-III lineage; AA, Asian-American genotype; AI, Asian I genotype; AII, Asian II genotype; AM, American genotype. (B) ML phylogenetic tree generated using 129 C/PrM gene sequences of the Cosmopolitan genotype only. The additional Kenyan sequences that were included in this dataset are colored with blue tip-labels.](veaa026f1){#veaa026-F1}

ML phylogeny for the partial C/PrM gene, including additional sequences from Kenya, recovered one additional sequence from Mombasa that belonged to the C-II lineage ([Fig. 1B](#veaa026-F1){ref-type="fig"}). The other additional five sequences, all from the Kenyan Coast, fell under the C-I lineage ([Fig. 1B](#veaa026-F1){ref-type="fig"}). This finding agrees with our observation that C-I lineage was the most predominant during the 2013--4 outbreak and reinforces the evidence of the existence of C-II lineage in Mombasa during this outbreak period. There was, however, no additional C-II lineage sequences from any other additional country, pointing to the possibility of this strain currently being present only in the countries identified before; Burkina Faso, Niger, and Kenya.

3.2 Strains causing DENV-2 outbreaks in Kenya were introduced independently
---------------------------------------------------------------------------

The molecular clock analyses indicate that the most recent common ancestor (MRCA) of the coastal Kenya outbreak strain existed in 2011 (2011.57; 95% HPD: 2010.83, 2012.24) ([Fig. 2](#veaa026-F2){ref-type="fig"}), making this the most probable latest time point of introduction of this particular strain to the Kenyan coast. We estimated the evolutionary rates of this particular strain under the uncorrelated lognormal clock (UCLN) and our findings showed that the mean nucleotide substitution rates of this strain was 1.6631E−3 substitutions/site/year (95% HPD: 6.0638E−4, 3.1978E−3), which was not significantly different from the nucleotide substitution rates of the entire cosmopolitan genotype, 8.403E−4 substitutions/site/year (95% HPD: 7.4527E−4, 9.3025E−4). These findings were consistent with previous evolutionary rate estimates for DENV2, 8.94E−4 substitutions/site/year (95% HPD: 7.39E−4, 1.04E−3 ([@veaa026-B55]). Discrete state reconstruction puts, with high confidence, the origin location of the ancestral strain in South Asia and most probably India, where most of the closely related isolates came from (PP = 0.9).

![Time-calibrated phylogeny based on 110 cosmopolitan genotype sequences from different countries. The Kenyan sequences are colored in green tip-labels and the tree branches are colored based on the inferred geographical location of origin.](veaa026f2){#veaa026-F2}

The MRCA of the Wajir/Mombasa strain existed in Kenya in early 2013 (2013.31; 95% HPD: 2013.07, 2013.38) ([Fig. 2](#veaa026-F2){ref-type="fig"}) with the discrete state reconstruction putting the origin location of this strain's MRCA in Africa (PP = 0.7). This strain shared an ancestor with genomes from Burkina Faso, which were isolated since 1983 and the ancestor existed in late 1979 (1979.82; 95% HPD: 1978.22, 1981.39). This strain was, therefore, introduced to Kenya between September 1979 and March 2013.

4. Discussion
=============

DENV-2 has been the dominant serotype reported during dengue outbreaks in Kenya since the 1980s ([@veaa026-B19]; [@veaa026-B24]; [@veaa026-B26]; [@veaa026-B14]). The outbreak that occurred in 1982 was considered to be extensive and although little information is available as to the extent of this outbreak, one group tested forty-three acutely ill patients and obtained seven virus isolates ([@veaa026-B19]). Furthermore, the antibody prevalence rate during this outbreak period rose from 7.6 in June, 1982 to 52 percent in October the same year ([@veaa026-B56]). The next set of outbreaks was reported between 2011 and 2014 and more recently between 2017 and 2018. The 2011--4 outbreak involved DENV-1, 2, and 3 ([@veaa026-B58], [@veaa026-B24]; [@veaa026-B26]) and the 2017 outbreak involved DENV-2 ([@veaa026-B61]; [@veaa026-B14]). These two outbreaks caused high public health burden, involving thousands of cases and multiple fatalities ([@veaa026-B38]; [@veaa026-B34]; [@veaa026-B47]; [@veaa026-B12]; [@veaa026-B61]). In this study, we investigated the evolutionary origins of DENV-2 that caused these recent outbreaks in Kenya by analyzing DENV-2 sequence data obtained during the outbreak in coastal Kenya and Wajir between 2013 and 2017.

The most significant finding from this study is the revelation of the presence of two different lineages of DENV-2 Cosmopolitan genotype, C-I and C-II, in Kenya. It is important to note that after the initial emergence of the Cosmopolitan genotype, there was early separation of C-I and C-II/C-III lineages, leading to emergence of the two clearly defined lineages. Our findings show that this early separation occurred by April 1958 (95% HPD: 1950.46, 1963.89), with the C-II and C-III lineages separating by January 1961 (95% HPD: 1956.85, 1964.63) ([Fig. 2](#veaa026-F2){ref-type="fig"}). It, therefore, follows that the two lineages circulating in Kenya had separated by April, 1958. Our phylogenetic analysis show that the majority of the isolates from the coastal Kenya outbreak (Coastal Kenya strain) fell within the C-I lineage and the isolate from Wajir, together with two isolates from Mombasa (Wajir/Mombasa strain), fell within the C-II lineage. This, therefore, points to a more significant impact of the C-I lineage during the recent DENV-2 outbreaks in Kenya as compared with the C-II lineage.

The C-I lineage contains DENV-2 genomes predominantly from South Asia. There are also sporadic isolations of this lineage in East Asia, particularly South Korea and China. Sequences isolated recently in the islands of Reunion and Seychelles also fell within this lineage. However, the strains that caused this Indian Ocean islands (Seychelles and Reunion) epidemic ([@veaa026-B37]) do not appear to have any link to the coastal Kenya outbreak strain. Our analysis show that the C-I lineage was introduced into the Kenyan coast between March 2010 and June 2011 and it led to successful local transmission of DENV-2, as evidenced during the outbreak in Mombasa in 2013--4 ([@veaa026-B24]; [@veaa026-B26]). This outbreak was responsible for at least 153 confirmed cases and 1 fatality ([@veaa026-B34]; [@veaa026-B12]). The C-II lineage, on the other hand, clustered together with DENV-2 genomes from Burkina Faso and Indonesia as well as one genome from Niger. This lineage appears to have been introduced into Kenya between September 1979 and March 2013. It was isolated during both the Coastal and northeastern Kenya outbreaks in 2013--4. The outbreak in northeastern Kenya in 2011 and in 2013 was responsible for at least 5,300 documented cases (with at least thirteen fatalities) ([@veaa026-B38]; [@veaa026-B47]). Only one genome from Wajir was available in this study and, therefore, we cannot make any conclusion on the lineage or the DENV serotype that was mostly involved in that particular outbreak. Nonetheless, the Kenyan dengue outbreak between 2011 and 2014 involved DENV-1, 2, and 3 and the co-occurrence of these three serotypes may have played a major role in the extended nature of this outbreak as well as the increased number of cases and fatalities reported ([@veaa026-B11]). However, the contribution of DENV-2 was also quite significant considering that it was the most commonly isolated serotype during 2013 and 2014 ([@veaa026-B24]).

DENV-2 further reemerged in both Mombasa and Wajir counties in 2017, after a period of more than 2 years. This outbreak also involved large number of cases, with 82 cases being reported in Wajir and a much larger number of at least 1,117 cases (with one fatality) being reported in Mombasa county as of July 2017 ([@veaa026-B61]). Our analysis of all the sequences from Mombasa and Kilifi Counties which were obtained during the outbreak in 2017 showed that all the isolates were of the C-I lineage. Put together, these findings show the establishment and expansion of the C-I lineage and its increased impact in regard to DENV outbreaks in Kenya.

Our analysis of the probable geographic origins of the currently circulating DENV-2 strains showed South Asia as the epicenter of C-I outbreaks, with evidence of seeding to other countries in East Asia, South East Asia, and much more recently in Africa (Kenya, Seychelles, and Reunion). The introduction of this strain into Kenya was estimated to have occurred from this particular region, and most probably from India where most of the closely related strains came from. This may be due to the interconnection between Mombasa and various countries in South Asia, particularly India ([@veaa026-B7]). The coastal city of Mombasa is East Africa's main shipping port and an international tourist destination; thus, it may serve as the entry point of DENVs and mosquito vectors through tourism and intercontinental trade. Indeed, a previous study on Chikungunya has supported this hypothesis whereby a strain of Chikungunya that caused an outbreak in northeastern Kenya in 2016 was found to have been introduced into Kenya from India ([@veaa026-B27]). At the same time, seeding of Chikungunya to the Indian Ocean Islands and the Indian mainland was shown to have happened from this location ([@veaa026-B50]), where it triggered one of the worst CHIKV epidemics between 2004 and 2007 ([@veaa026-B8]; [@veaa026-B9]; [@veaa026-B22]). Our results, therefore, support this previous finding and can be explained by the fact that dengue and Chikungunya are transmitted by the same mosquito vector species. This intercontinental network between the Coastal city of Mombasa and countries in South Asia, therefore, provides a nexus for transmission of dengue between Mombasa and South Asia and may have been the channel through which C-I lineage was introduced into Kenya. The C-II lineage strain appears to have been introduced into Kenya possibly from Burkina Faso. However, the long branch as well as the estimated time of introduction between September 1979 and March 2013 points to missing data. Likewise, this lack of genomic data makes it impossible to estimate with certainty the geographical distribution of this strain over time. It is noteworthy to point out that the Wajir/Mombasa strain diverged from Burkina Faso strains in September 1979 (95% HPD: 1978.22, 1981.39). Considering the first documented DENV-2 outbreak at the Kenyan coast was in 1982 ([@veaa026-B19]), it is plausible that the ancestral strains of the Wajir/Mombasa strain were responsible for DENV-2 outbreak during that period ([@veaa026-B19]). However, more sequence data from previous Kenyan dengue outbreaks, would confirm whether this strain was responsible for the outbreak experienced in 1982 and later periods. The phylogenetic analysis showed the C-II lineage to have little representation with regard to the number of available sequences. Unlike the C-I lineage which has been implicated in numerous outbreaks across Asia and Africa, the only recent documented epidemic driven by C-II lineage is the Burkina Faso outbreak of 2016 ([@veaa026-B60]; [@veaa026-B3]). Prior to this outbreak, C-II had only been isolated in Indonesia in 1975--6 and in Burkina Faso in 1983. The lack of data for this particular lineage could be due to lack of surveillance in areas where it is most common, possibly in Africa and/or Asia. Alternatively, this could also be explained by the intrinsic factors that are particular to C-II lineage of DENV-2. Nevertheless, we cannot explain with certainty the reasons why this lineage is rarely isolated compared with the other Cosmopolitan genotype lineages. It is, however, worth noting that the recent outbreaks reported in Burkina Faso in 2016 were driven by this lineage (C-II) where it was associated with at least 1,061 cases with fifteen fatalities ([@veaa026-B60]; [@veaa026-B3]). This epidemic continued into 2017, where DENV-1, 2, and 3 were identified during this outbreak period ([@veaa026-B41]; [@veaa026-B61]). Considering DENV-2 was among the serotypes identified, it is possible that the C-II lineage was also responsible for the DENV-2 cases during this Burkina Faso 2017 outbreak.

5. Conclusion
=============

This study has shown that recent epidemics associated with DENV-2 in Kenya were predominantly driven by the newly introduced C-I lineage, which was introduced to Kenya between March 2010 and June 2011 from South Asia, and which subsequently spread and contributed to the DENV-2 outbreak in 2013/4 and 2017. The intercontinental link of the spread, therefore, shows that both local and international strategies should be considered when designing interventions to curb DENV-2 transmission in Kenya and the region. We have also described a comparatively divergent strain of DENV-2, C-II, which may have been circulating in this region since the 1980s. Even though this strain was least isolated during the outbreak in 2013--4, its role in the 2016 Burkina Faso outbreak points to the potential for this strain to cause local epidemics and thus continued surveillance efforts on DENV activity are important for effective control.
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